ImmunoPrecise Antibodies (IPA)

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

INK Ultra Money: Girl power propels junior biotech stock higher

Today, INK Research turns its attention to a Canadian biotechnology stocks that has been soaring on the back of renewed investor interest in the Canadian Healthcare sector. Two years ago, investors flocked to the group to chase pot stocks. This time around, investors seem to be more interested in genuine health care names that focus on using scientific research to develop therapeutics for COVID-19 and other ailments. Watch the free video summary below.

INK Ultra Money: The Fed, bitcoin, and health care

While it was easy to miss in the wake of the Fed meeting, bitcoin has edged closer to $10,0000. For the past couple of weeks, it has been consolidating, so we shall see if it can sneak across that psychological barrier. On INK Ultra Money we heard from Arthur Hayes, CEO and co-founder of BitMEX a cryptocurrency exchange and derivatives platform. It is a timely interview as signs are pointing to incremental institutional interest in the space.

Today, Galaxy Digital ( GLXY) announced a trading and custody solution for institutions and accredited investors. This is a critical piece of the bitcoin adoption equation and points to further momentum in the space.

Revisiting crypto as bitcoin toys with $10,000

On that front, I would encourage investors who are interested in owning bitcoin but have not taken the plunge to put an action plan together. You will need both a trading platform and a custody solution. The time to get those two elements in place is now, not when investor excitement returns to the space.

COVID-19 stocks are flying as Raoul Pal goes live with a recession update

Today is a busy day at INK. At the close we are rebalancing the 50-stock INK Canadian Insider (CIN) Index. Over the past week we have been highlighting some of the new entrants and in the Friday morning report we highlighted newcomer Mullen Group ( MTL). There is obviously a lot of uncertainty about the economy's path due to COVID-19. However, there is some hope emerging among biotech stocks that maybe some treatments might be on the way. In particular, two stocks focusing on anti-body research that we featured in INK Chat are rallying Friday.

The big winner is Sorrento Therapeutics (SRNE) which is up more than 150% based on a Fox News story that the company is claiming to have an effective treatment. Nicholas Winton who writes the weekly INK CIN technical blog highlighted this stock in INK Chat on May 11th.

Subscribe to RSS - ImmunoPrecise Antibodies (IPA)